Industry
Drug Manufacturers - Specialty & Generic
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, which is a prescription drug approved for use in combination with the company's licensor's medical device; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription cream for the treatment of impetigo. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Loading...
Open
1.08
Mkt cap
8.2M
Volume
506K
High
1.16
P/E Ratio
0.91
52-wk high
4.00
Low
1.01
Div yield
N/A
52-wk low
0.61
Portfolio Pulse from
November 14, 2024 | 1:30 am
Portfolio Pulse from
November 13, 2024 | 10:30 pm
Portfolio Pulse from Benzinga Insights
November 01, 2024 | 4:36 pm
Portfolio Pulse from Benzinga Insights
November 01, 2024 | 12:12 pm
Portfolio Pulse from Benzinga Insights
November 01, 2024 | 12:11 pm
Portfolio Pulse from Benzinga Insights
October 31, 2024 | 8:34 pm
Portfolio Pulse from Benzinga Insights
October 31, 2024 | 4:34 pm
Portfolio Pulse from Benzinga Newsdesk
October 31, 2024 | 4:14 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.